Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas

Journal of Neurosurgery - Tập 49 Số 3 - Trang 333-343 - 1978
Michael Walker, Eben Alexander, William E. Hunt, Collin S. MacCarty, M. S. Mahaley, John Mealey, Horace Norrell, Guy Owens, Joseph Ransohoff, Charles B. Wilson, Edmund A. Gehan, Thomas A. Strike

Tóm tắt

✓ A controlled, prospective, randomized study evaluated the use of 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) and/or radiotherapy in the treatment of patients who were operated on and had histological confirmation of anaplastic glioma. A total of 303 patients were randomized into this study, of whom 222 (73%) were within the Valid Study Group (VSG), having met the protocol criteria of neuropathology, corticosteroid control, and therapeutic approach. Patients were divided into four random groups, and received BCNU (80 mg/sq m/day on 3 successive days every 6 to 8 weeks), and/or radiotherapy (5000 to 6000 rads to the whole brain through bilateral opposing ports), or best conventional care but no chemotherapy or radiotherapy. Analysis was performed on all patients who received any amount of therapy (VSG) and on the Adequately Treated Group (ATG), who had received 5000 or more rads radiotherapy, two or more courses of chemotherapy, and had a minimum survival of 8 or more weeks (the interval that would have been required to have received either the radiotherapy or chemotherapy). Median survival of patients in the VSG was, best conventional care: 14 weeks (ATG: 17.0 weeks); BCNU: 18.5 weeks (ATG: 25.0 weeks); radiotherapy: 35 weeks (ATG: 37.5 weeks); and BCNU plus radiotherapy: 34.5 weeks (ATG: 40.5 weeks). All therapeutic modalities showed some statistical superiority compared to best conventional care. There was no significant difference between the four groups in relation to age distribution, sex, location of tumor, diagnosis, tumor characteristics, signs or symptoms, or the amount of corticosteroid used. An analysis of prognostic factors indicates that the initial performance status (Karnofsky rating), age, the use of only a surgical biopsy, parietal location, the presence of seizures, or the involvement of cranial nerves II, III, IV, and VI are all of significance. Toxicity included acceptable, reversible thrombocytopenia and leukopenia.

Từ khóa


Tài liệu tham khảo

Frankel, 1958, Glioblastoma multiforme. Review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment., 15, 489, 10.3171/jns.1958.15.5.0489

Gehan, 1965, A generalized Wilcoxon test for comparing arbitrarily singly-censored samples., 52, 203, 10.1093/biomet/52.1-2.203

Gehan, Prognostic factors for patients with brain tumors.

Goldsmith, 1974, Glioblastoma multiforme — a review of therapy., 1, 153, 10.1016/S0305-7372(74)80016-2

Jelsma, 1967, The treatment of glioblastoma multiforme of the brain., 27, 388, 10.3171/jns.1967.27.5.0388

Kaplan, 1958, Nonparametric estimation from incomplete observations., 53, 457, 10.1080/01621459.1958.10501452

Karnofsky, 1951, Triethylene melamine in the treatment of neoplastic disease., 87, 477, 10.1001/archinte.1951.03810040002001

Levin, 1975, A pharmacologic basis for brain tumor chemotherapy., 2, 57

Mahaley, Neuropathology observations on tissues from patients treated by the Brain Tumor Study Group (BTSG).

Rubinstein, 1972

Russell, 1970

Schabel, 1963, Experimental evaluation of potential anticancer agents. VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia., 23, 725

Snedecor, 1967, 215

Vendetti, 1964, Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VIII., 24, 827

Walker, 1973, Brain and peripheral nervous system tumors, 1385

Walker, 1976, The evaluation of mithramycin in the treatment of anaplastic gliomas., 44, 655, 10.3171/jns.1976.44.6.0655

Walker, 1970, BCNU 1,3-bis(2-chloroethyl)-1-nitrosourea; (NSC-409962) in the treatment of malignant brain tumor — a preliminary report., 54, 263

Walker, 1976, An evaluation of Methyl-CCNU, BCNU and radiotherapy in the treatment of malignant glioma., 17, 163

Wilson, 1970, 1,bis(2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors., 54, 273

Thông tin
Thông tin xuất bản

Journal of Neurosurgery

Tập 49 Số 3

333-343

Thông tin tác giả